Sterling Biotech to acquire gelatin manufacturing facility in China

Sterling Biotech Ltd has announced that the Company will acquire gelatin manufacturing facility in China i.e. China Gelatin Ltd. This acquisition will be first overseas acquisition by the company.

The Initiative is in line with the Company's philosophy of focusing on the growth market globally.

The acquisition will enable the Company to tap new Growth Markets in Far East Asia including China. China is amongst major consumers of Gelatin Globally.

The transaction will be all cash deal and will be completed upon receipt of all necessary govt. approval / consents under applicable laws by each party.

Source : Equity Bulls

Keywords